MaxCyte (MXCT)

• Market cap: $164M
• 1 day: -5.52%
• 5 days: -12%
• 1 month: 2.67%
• 3 months: -31.86%
• 6 months: -47.26%
• Year to date: -62.89%
• 1 year: -57.34%
• 5 years: -90.94%
• 10 years: -90.94%
• Sector: Healthcare
• Industry: Medical Devices

About: MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Employees: 114